Fennec Pharmaceuticals (FENC) Free Cash Flow (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -499.33% |
| Sep 30, 2025 | 140.50% |
| Jun 30, 2025 | 14.64% |
| Mar 31, 2025 | -192.94% |
| Dec 31, 2024 | 33.18% |
| Sep 30, 2024 | 73.70% |
| Jun 30, 2024 | -122.48% |
| Mar 31, 2024 | 867.63% |
| Dec 31, 2023 | -76.09% |
| Sep 30, 2023 | 30.06% |
| Jun 30, 2023 | 29.25% |
| Mar 31, 2023 | 18.01% |
| Dec 31, 2022 | -35.77% |
| Sep 30, 2022 | -47.79% |
| Jun 30, 2022 | -18.70% |
| Mar 31, 2022 | 11.99% |
| Dec 31, 2021 | -9.70% |
| Sep 30, 2021 | 33.17% |
| Jun 30, 2021 | -23.18% |
| Mar 31, 2021 | -9.41% |
| Dec 31, 2020 | 39.70% |
| Sep 30, 2020 | -74.78% |
| Jun 30, 2020 | 16.88% |
| Mar 31, 2020 | -135.79% |
| Dec 31, 2019 | 28.86% |
| Sep 30, 2019 | 18.90% |
| Jun 30, 2019 | -11.17% |
| Mar 31, 2019 | 15.39% |
| Dec 31, 2018 | -83.24% |
| Sep 30, 2018 | -1.85% |
| Jun 30, 2018 | 9.09% |
| Mar 31, 2018 | -30.83% |
| Dec 31, 2017 | -37.79% |
| Sep 30, 2017 | -39.24% |
| Jun 30, 2017 | -1.93% |
| Mar 31, 2017 | -10.47% |
| Dec 31, 2016 | -12.32% |
| Sep 30, 2016 | -15.74% |
| Jun 30, 2016 | 5.81% |
| Mar 31, 2016 | -17.69% |
| Dec 31, 2015 | 16.70% |
| Sep 30, 2015 | 0.39% |
| Jun 30, 2015 | -22.25% |
| Mar 31, 2015 | 10.68% |
| Dec 31, 2014 | -5.64% |
| Sep 30, 2014 | -8.05% |
| Jun 30, 2014 | -8.47% |
| Mar 31, 2014 | 15.06% |
| Dec 31, 2013 | 5.12% |
| Sep 30, 2013 | 47.24% |
| Jun 30, 2013 | -118.43% |
| Mar 31, 2013 | 26.93% |
| Dec 31, 2012 | 23.28% |
| Sep 30, 2012 | 35.92% |
| Jun 30, 2012 | -96.02% |
| Mar 31, 2012 | 24.64% |
| Dec 31, 2011 | -20.60% |
| Sep 30, 2011 | -135.89% |
| Jun 30, 2011 | 269.08% |
| Mar 31, 2011 | -60.00% |
| Dec 31, 2010 | -19.09% |
| Sep 30, 2010 | -42.49% |